Ultrasound-Guided Filler Dissolving in Istanbul: A Targeted Assessment

Ultrasound-guided filler dissolving in Istanbul uses imaging to locate previous filler and, when appropriate, guide hyaluronidase toward the deposit. Ultrasound does not dissolve filler itself, and hyaluronidase cannot dissolve every filler material.

What does ultrasound add?

High-frequency ultrasound can help a clinician examine a deposit’s position, tissue plane and relationship to nearby vessels in real time. A clinical publication describes visualising hyaluronic acid filler and surrounding tissues and directing hyaluronidase into a visible deposit. Imaging supports assessment; it does not replace examination or prove the cause of every lump, shadow or contour change.

Which fillers can be dissolved?

Hyaluronidase is used to break down hyaluronic acid filler. Calcium hydroxylapatite, poly-L-lactic acid, silicone and permanent materials do not become dissolvable simply because ultrasound is used. The FDA’s patient information notes that removing permanent or non-HA filler can be difficult or impossible. When the product is unknown, prior records, examination and imaging must be interpreted together.

Who may be considered?

Assessment may be reasonable for a person concerned about migration, irregularity, superficial visibility, asymmetry or unwanted volume after a known or suspected HA filler. Active infection, unexplained pain, marked inflammation or a significant allergy history may alter or postpone a plan. A decision should not be made from photographs alone; timing, product history and examination matter.

Limits and alternatives

No clinician can promise restoration of an exact former appearance, complete dissolution in one visit or perfect symmetry. Response can vary with material, amount, distribution and tissue location. Observation, waiting for a temporary filler to diminish, investigating infection or inflammation, or referral for a non-HA or permanent material may be safer than proceeding directly to enzyme treatment.

Preparing and following up

Bring the product name, treatment date, treated sites, records of previous dissolving sessions and a current medication list when available. Temporary tenderness, redness, swelling or bruising can follow an injection, and an allergic reaction is possible. Follow-up checks the changing contour and symptoms; the need for any further procedure is judged clinically rather than promised in advance.

Emergency or elective appointment?

Sudden loss or change of vision, double vision, unusual pain, an abnormal white, grey or blue change in skin near the injection site, or stroke symptoms are emergencies. The FDA advises immediate medical attention for these warning signs. Do not wait for an elective clinic appointment. Stable, non-urgent concerns about old filler can be assessed at the Istanbul Maslak clinic. For broader context, see the under-eye filler guide.

Related guides

• Ultrasound-Guided Filler Dissolving service
• Under-Eye Filler Guide
• Injectables Around the Eyes

Sources

• FDA — Dermal Fillers (Soft Tissue Fillers)
• Ultrasound to improve the safety of hyaluronic acid filler treatments
• Ultrasound detection and identification of cosmetic fillers in the skin

This content provides general information, not a diagnosis or personal treatment recommendation. Suitability, risks and alternatives require an individual medical assessment.

The cover is an AI-generated conceptual illustration; it does not show a patient or treatment result.